Shifeng Chu

5.0k total citations
128 papers, 3.9k citations indexed

About

Shifeng Chu is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Shifeng Chu has authored 128 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 37 papers in Neurology and 19 papers in Cellular and Molecular Neuroscience. Recurrent topics in Shifeng Chu's work include Neuroinflammation and Neurodegeneration Mechanisms (31 papers), Ginseng Biological Effects and Applications (25 papers) and Connexins and lens biology (12 papers). Shifeng Chu is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (31 papers), Ginseng Biological Effects and Applications (25 papers) and Connexins and lens biology (12 papers). Shifeng Chu collaborates with scholars based in China, Canada and United States. Shifeng Chu's co-authors include Nai‐Hong Chen, Zhao Zhang, Yan Gao, Juntian Zhang, Qidi Ai, Xin‐Fu Zhou, Cong‐Yuan Xia, Yingjiao Liu, Wenbin He and Zhen‐Zhen Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Brain Research.

In The Last Decade

Shifeng Chu

126 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shifeng Chu China 38 1.9k 879 567 446 417 128 3.9k
Qihai Gong China 44 2.1k 1.2× 778 0.9× 884 1.6× 309 0.7× 336 0.8× 149 4.9k
Mohammad Moshahid Khan United States 39 1.7k 0.9× 891 1.0× 320 0.6× 272 0.6× 372 0.9× 92 4.7k
Yunman Li China 39 1.8k 1.0× 1.0k 1.1× 382 0.7× 361 0.8× 490 1.2× 157 4.1k
Kumar Vaibhav United States 33 1.1k 0.6× 651 0.7× 292 0.5× 264 0.6× 291 0.7× 64 3.5k
Qin Wu China 38 1.6k 0.9× 388 0.4× 728 1.3× 343 0.8× 235 0.6× 135 4.0k
Tauheed Ishrat United States 41 1.9k 1.0× 1.4k 1.6× 203 0.4× 492 1.1× 307 0.7× 110 5.1k
Ying Pan China 31 1.4k 0.7× 278 0.3× 559 1.0× 380 0.9× 200 0.5× 65 3.3k
Xinbing Wei China 39 2.0k 1.1× 872 1.0× 160 0.3× 409 0.9× 641 1.5× 72 4.0k
Guo‐qing Zheng China 36 1.2k 0.7× 960 1.1× 481 0.8× 364 0.8× 117 0.3× 133 3.8k
Dong‐Young Choi South Korea 33 1.1k 0.6× 900 1.0× 179 0.3× 199 0.4× 274 0.7× 76 3.3k

Countries citing papers authored by Shifeng Chu

Since Specialization
Citations

This map shows the geographic impact of Shifeng Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shifeng Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shifeng Chu more than expected).

Fields of papers citing papers by Shifeng Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shifeng Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shifeng Chu. The network helps show where Shifeng Chu may publish in the future.

Co-authorship network of co-authors of Shifeng Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Shifeng Chu. A scholar is included among the top collaborators of Shifeng Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shifeng Chu. Shifeng Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Ye, et al.. (2025). Targeting and reprogramming microglial phagocytosis of neutrophils by ginsenoside Rg1 nanovesicles promotes stroke recovery. Bioactive Materials. 47. 181–197. 5 indexed citations
2.
Li, Xiumei, Jun Jiang, Yan Yang, et al.. (2025). Opportunities for the treatment of atherosclerosis: Selectins. Pharmacological Research. 217. 107807–107807.
3.
Wang, Shasha, Wenfei Wang, Wenbin He, et al.. (2025). Spike RBD drives sustained Parkinson’s disease progression via microglia-neuron crosstalk-mediated RTP801 upregulation. Journal of Advanced Research. 1 indexed citations
4.
Wang, Hongyun, Ye Peng, Shasha Wang, et al.. (2025). Noncanonical role of astrocytic mitochondrial Cx43: suppressing IDH3α to sustain glycolytic homeostasis against depression. Cell Death and Disease. 17(1). 94–94.
5.
Chen, Haodong, Yangbo Liu, Qidi Ai, et al.. (2024). Ferroptosis is Involved in the Pharmacological Effect of Ginsenoside. Mini-Reviews in Medicinal Chemistry. 24(13). 1228–1237. 1 indexed citations
6.
Ai, Qidi, et al.. (2023). Characteristics and pathogenesis of chemokines in the post-stroke stage. International Immunopharmacology. 116. 109781–109781. 7 indexed citations
7.
Wang, Jie, et al.. (2023). Impact of Codonopsis decoction on cerebral blood flow and cognitive function in rats with chronic cerebral ischemia. Journal of Ethnopharmacology. 323. 117585–117585. 8 indexed citations
8.
Chu, Shifeng, et al.. (2023). Regulation of oxygen–glucose deprivation/reperfusion-induced inflammatory responses and M1-M2 phenotype switch of BV2 microglia by lobetyolin. Metabolic Brain Disease. 38(8). 2627–2644. 11 indexed citations
9.
Wang, Shasha, Wenbin He, Zhong‐Ping Feng, et al.. (2023). A small molecule 20C from Gastrodia elata inhibits α-synuclein aggregation and prevents progression of Parkinson’s disease. Cell Death and Disease. 14(9). 594–594. 11 indexed citations
10.
Cui, Liyuan, Zhao Zhang, Zhong‐Ping Feng, et al.. (2023). A novel small-molecular CCR5 antagonist promotes neural repair after stroke. Acta Pharmacologica Sinica. 44(10). 1935–1947. 21 indexed citations
11.
Chu, Shifeng, et al.. (2023). Time-dependent dual effect of microglia in ischemic stroke. Neurochemistry International. 169. 105584–105584. 20 indexed citations
12.
Li, Dongmei, Sheng Wang, Shifeng Chu, et al.. (2022). Mahonia Alkaloids (MA) Ameliorate Depression Induced Gap Junction Dysfunction by miR-205/Cx43 Axis. Neurochemical Research. 47(12). 3761–3776. 11 indexed citations
13.
Zhou, Xin‐Fu, Yani Zhang, Fangfang Li, et al.. (2021). Neuronal chemokine-like-factor 1 (CKLF1) up-regulation promotes M1 polarization of microglia in rat brain after stroke. Acta Pharmacologica Sinica. 43(5). 1217–1230. 34 indexed citations
14.
Zhu, Jie, Shifeng Chu, Ye Peng, et al.. (2021). Pyk2 inhibition attenuates hypoxic-ischemic brain injury in neonatal mice. Acta Pharmacologica Sinica. 43(4). 797–810. 8 indexed citations
15.
Gao, Yan, Juntong Li, Jin Wang, et al.. (2020). Ginsenoside Rg1 prevent and treat inflammatory diseases: A review. International Immunopharmacology. 87. 106805–106805. 84 indexed citations
16.
Zhao, Ming, Zhao Zhang, Liyuan Cui, et al.. (2020). Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-κB signaling and modulation of M1/M2 polarization. Acta Pharmacologica Sinica. 41(4). 523–534. 58 indexed citations
17.
Chu, Shifeng, Qingxin Guo, Fangfang Li, et al.. (2020). Combination of monoammonium glycyrrhizinate and cysteine hydrochloride ameliorated lipopolysaccharide/galactosamine-induced acute liver injury through Nrf2/ARE pathway. European Journal of Pharmacology. 882. 173258–173258. 10 indexed citations
18.
Chen, Chen, Qidi Ai, Shifeng Chu, et al.. (2019). IMM-H004 protects against oxygen-glucose deprivation/reperfusion injury to BV2 microglia partly by modulating CKLF1 involved in microglia polarization. International Immunopharmacology. 70. 69–79. 18 indexed citations
19.
Luo, Piao, et al.. (2018). Lipid metabolism in Alzheimer’s disease. Brain Research Bulletin. 144. 68–74. 41 indexed citations
20.
Zang, Yingda, Xiu‐Yun Song, Chuang‐Jun Li, et al.. (2017). Pyrano[3,2-a]carbazole alkaloids as effective agents against ischemic stroke in vitro and in vivo. European Journal of Medicinal Chemistry. 143. 438–448. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qihai Gong Breakdown of academic impact, for papers by Mohammad Moshahid Khan Breakdown of academic impact, for papers by Yunman Li Breakdown of academic impact, for papers by Kumar Vaibhav Breakdown of academic impact, for papers by Qin Wu Breakdown of academic impact, for papers by Tauheed Ishrat Breakdown of academic impact, for papers by Ying Pan Breakdown of academic impact, for papers by Xinbing Wei Breakdown of academic impact, for papers by Guo‐qing Zheng Breakdown of academic impact, for papers by Dong‐Young Choi
Rankless by CCL
2026